Target intelligence / Profile preview

Bone marrow hematopoietic stem cell niche (HSC niche)

Target
HSC niche
Molecular classification
Other
01

Overview

The bone marrow hematopoietic stem cell niche is a highly specialized microenvironment that governs the maintenance, self-renewal, and differentiation of hematopoietic stem cells (HSCs). It is anatomically divided into the endosteal (or osteoblastic) niche, which is located near the bone surface and promotes HSC quiescence, and the perivascular niche, which is situated near blood vessels and facilitates HSC proliferation and mobilization into the circulation. This complex system involves interactions between HSCs and various cellular components, including osteoblasts, mesenchymal stem cells, endothelial cells, and immune cells, mediated by signaling axes such as CXCL12/CXCR4 and SCF/c-Kit. In pathological states like leukemia and metastatic cancer, the niche can be hijacked to protect malignant cells from chemotherapy, leading to drug resistance and disease recurrence. Consequently, the niche is a critical therapeutic target; drugs like Plerixafor and G-CSF are routinely used to mobilize HSCs for transplantation, while newer strategies aim to disrupt the protective environment to sensitize cancer cells to treatment.

Other names
Hematopoietic stem cell nicheBone marrow nicheHSC microenvironmentOsteoblastic nichePerivascular nicheEndosteal niche
02

Mechanism of action

Mobilization of hematopoietic stem cells via CXCR4 antagonism, disruption of E-selectin-mediated adhesion, and modulation of the bone marrow microenvironment through cytokine signaling and osteoblast inhibition.

03

Biological functions

HematopoiesisStem cell maintenanceCell proliferationCell differentiationImmune responseCell cycle regulationHomingMobilization
04

Disease associations

CancerInflammationLeukemiaMyelodysplastic syndromeBone marrow failureMetastasis
05

Safety considerations

Splenic ruptureBone painHyperleukocytosisMobilization of malignant cellsGraft-versus-host disease (GVHD)Allergic reactions
06

Interacting drugs

Plerixafor (AMD3100)

6 more in the full profile.

07

Biomarkers

CD34+ cell countCXCL12 (SDF-1) levelsStem cell factor (SCF) levelsOsteopontinE-selectin expression

Beyond the preview

Go deeper on Bone marrow hematopoietic stem cell niche (HSC niche).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bone marrow hematopoietic stem cell niche (HSC niche).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call